Overview

Botswana Smoking and Abstinence Reinforcement Trial

Status:
Not yet recruiting
Trial end date:
2027-08-31
Target enrollment:
Participant gender:
Summary
Many people living with HIV in southern Africa, specifically Botswana use tobacco products. Using tobacco makes some of the effects of HIV worse and even causes excess deaths. The investigators plan to use an intervention called Screening, Brief Intervention and Referral to Treatment (SBIRT) to help people to quit smoking and also a drug called varenicline. Apart from helping people to stop smoking, the investigators will also test to see how task shifting can be used to help people stop smoking in a sustainable way. Finally, the investigators will estimate the cost of the intervention.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland, Baltimore
Collaborators:
University of Kentucky
University of Maryland, Baltimore County
University of Maryland, College Park
Treatments:
Varenicline